Fig. 4

Kaplan-Meier graphs of (A) OS and (B) PFS in patients without baseline liver metastases who received IO + ChT versus ChT-alone. ChT indicates chemotherapy; IO, immunotherapy; CI, confidence interval; HR, hazard ratio; OS, overall survival; PFS, progression-free survival